摘要
目的本文主要是探讨和分析卵巢浆液性癌病理发病机制。方法选择2014年9月至2015年9月来我院接受治疗的20例卵巢浆液性癌患者临床资料作为研究对象,对其病理发病机制进行分析和探讨。结果经过对20例患者临床资料进行分析和比较之后不难发现,卵巢癌早期不具有较为明显的临床表现,缺乏可靠、有效的生物学标志物,患者确诊时一般都到中晚期,因为该种疾病化疗具有显著的耐药性,预后较差。结论卵巢浆液性癌患者要能尽早接受治疗,适龄女性一旦出现任何相关症状,要能够积极接受诊断,从根本上降低该种病症的病死率。
Objective This paper is to investigate and analyze the pathogenesis of ovarian serous carcinoma. Methods The clinical data of 20 cases of ovarian serous carcinoma treated in our hospital from September 2015 to September 2014 were studied. Results After analysis and comparison of the clinical data of 20 patients, it is not difficult to find that the early stage of ovarian cancer has no obvious clinical manifestations, and the lack of reliable and effective biological markers, and the patients are generally in the middle and late stage, because the disease chemotherapy has significant resistance, the prognosis is poor. Conclusion Patients with ovarian serous carcinoma should be treated as soon as possible, and any related symptoms should be able to actively accept the diagnosis and reduce the mortality of the disease.
出处
《中国医药指南》
2016年第33期10-11,共2页
Guide of China Medicine
关键词
卵巢浆液性癌
病理发病机制
研究
Ovarian serous carcinoma
Pathological mechanism
Study